King International Investment Limited (0928.HK)
HKSE · HKD · Healthcare · Diagnostics & Research
HK$0.78 (-17.89%) as of
Key statistics
- Market cap
- 247.16M
- P/E (TTM)
- 78.00
- EPS (TTM)
- 0.010
- Dividend yield
- 0.00%
- 52-week range
- 0.333 – 1.590
- Beta
- 0.72
- Revenue (TTM)
- 143.23M
- Profit margin
- 1.29%
- Volume
- 315.78k
About King International Investment Limited
King International Investment Limited, an investment holding company, provides healthcare products and services in the People's Republic of China and Hong Kong. The company offers medical supplies, including medical thermometers, masks, protective clothing, disinfectant, virus testing kits and reagents, breathing machines, and other medical products, as well as value-added services. It is also involved in the money lending business; and sale of liquor. The company was formerly known as Life Healthcare Group Limited and changed its name to King International Investment Limited in December 2023. King International Investment Limited was incorporated in 2001 and is based in Central, Hong Kong.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Headquarters
- Central, Hong Kong
- Employees
- 13
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.